The exit comes as Trenkle accepts his new position at Novo Ventures, the venture capital arm of Novo Holdings.
![](https://globalventuring.com//content/uploads/2022/07/1657649897122-1.jpg)
Jim Trenkle announced his departure from the French corporate venture firm Sanofi Ventures, the corporate arm of pharmaceutical conglomerate Sanofi.
Trenkle will work as a partner for Denmark-based venture capital firm Novo Ventures, a subsidiary of Novo Holdings, which is part of global medical treatment foundation Novo Nordisk Foundation.
“After a wonderful couple years in Boston, I’m delighted to be back in the Bay Area…